Biofunctional Pharmaceutical Additives for Targeted, Improved Bioavailability and Safety of Medicine
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 10235
Special Issue Editors
Interests: preformulation studies; cyclodextrins; solubility enhancement; modified release systems; niosomes; ocular delivery; irritation models
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; cancer; pancreatic diseases; bioprinting; biosensor; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Interests: cancer nanomedicine; cytoplasmic drug delivery; targeted drug delivery; blood-brain barrier; ligand functionalised nanoparticles; liposomes; exosomes; extracellular vesicles
Special Issue Information
Dear Colleagues,
Conventional pharmaceutical excipients have been used to alter palatability, processing ability, flowability, and compressibility of dosage forms during manufacturing stages for producing elegant pharmaceutical products. Typical examples of these excipients include diluent, disintegrant, binder, lubricant, and glidant. Other pharmaceutical ingredients/excipients have been included to improve the chemical, physical, and microbial stability of the dosage forms. The literature has reported many drug–excipient incompatibilities and excipients-related side effects such as local irritation, interference at the absorption sites through affecting efflux pumps and g-glycoproteins, and other systemic toxicities.
With the recent advances in pharmaceutical and medical sciences, active pharmaceutical agents have been launched into the market with inherent poor biopharmaceutics properties such as low solubility and limited permeability. Erratic drug absorption, inconsistent bioavailability, irritation, and poor pharmacokinetics may occur, leading to suboptimal efficacy and adverse drug reactions.
Biofunctional excipients have recently emerged, such as smart polymers, lipids, and other safe and natural additives that can alter drug solubility, release characteristics, permeability, and pharmacokinetic profiles. Typical example include in situ forming polymers, amino acids, cyclodextrins, and many more.
The new knowledge obtained from novel research ideas and manuscripts will contribute to improving bioavailability, reducing adverse effects, achieving drug targeting, or promoting better patient treatment adherence.
The focus of this Special Issue is on recent developments in biofunctional non-active ingredients/excipients used to design pharmaceutical formulations and delivery systems (for topical or systemic routes) that could confer targeted drug delivery or modified drug release to enhance efficacy, reduce irritation at the absorption site, and beyond.
We would be much appreciating if you would consider being one of our authors contributing to this Special Issue. All types of submissions are welcome, including original research articles and comprehensive reviews.
Dr. Hamdy Abdelkader
Dr. Adel Al-Fatease
Dr. Zimei Wu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- excipients
- in situ forming polymers
- modified-release
- cyclodextrins
- amino acids
- eye diseases
- diabetes
- cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.